Hideaki Yamaguchi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hideaki Yamaguchi has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Hironori Umetsu
Laboratory of Food Chemistry, Department of Life Sciences, Junior College, Gifu Shotoku Gakuen University, 1‐38 Nakauzura, Gifu 500‐8288, Japan
7 shared publicationsKazuo Ryoyama
Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Aomori University, 2‐3‐1 Kobata, Aomori 030‐0943, Japan
7 shared publicationsYumi Kidachi
Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Aomori University, 2‐3‐1 Kobata, Aomori 030‐0943, Japan
7 shared publicationsKazuo Sasaki
3 shared publicationsJun Zhu
2 shared publicationsTao Yu
2 shared publications
Latest Publications
- 1 August 2008
- Published by Wiley in Cell Biology International
- Vol. 32 (8) , 940-949
Hypoxia enhances gene expression of inducible nitric oxide synthase and matrix metalloproteinase‐9 in ras/myc‐transformed serum‐free mouse embryo cells under simulated inflammatory and infectious conditions
Ras/myc‐transformed serum‐free mouse embryo (ras/myc SFME) cells were treated with interferon‐gamma (IFN‐γ; 100 U/ml) and/or lipopolysaccharide (LPS; 0.5 μg/ml) for 24 h to simulate inflammatory and infectious conditions and investigate their effects on the expression of inducible nitric oxide synthase (iNOS) mRNA, nitric oxide (NO) and matrix metalloproteinase‐9 (MMP‐9). In addition, aminoguanidine (AG; 1 mM), a NOS inhibitor, S‐nitroso‐N‐acetyl‐dl‐penicillamine (SNAP; 10–200 μM), an NO donor or (±)‐N‐[(E)‐4‐ethyl‐2‐[(Z)‐hydroxyimino]‐5‐nitro‐3‐hexene‐1‐yl]‐3‐pyridine carboxamide (NOR4; 10–200 μM), an NO donor, were added to analyze possible associations of NO with MMP‐9. Tissue inhibitors of metalloproteinase (TIMP)‐1 and TIMP‐2 were also measured to analyze possible relationships of NO with the MMP‐9/TIMP balance. Furthermore, the cells were treated with 1% O2 under the simulated inflammatory and infectious conditions and the mRNA expressions of iNOS and MMP‐9 were analyzed to investigate the possible effects of hypoxia on the expression of genes involved in tumor malignant progression and distant metastasis. Co‐treatment with IFN‐γ and LPS increased the expression levels of iNOS mRNA, NO and MMP‐9, but NO may not be directly associated with MMP‐9 or the MMP‐9/TIMP balance. Treatment with 1% O2 markedly increased the gene expression levels of iNOS and MMP‐9, indicating that ras/myc SFME cells alter the expression levels of tumor‐associated genes and possibly enhance their malignancy as cancer cells under inflammatory, infectious and hypoxic conditions.
- 1 August 2008
- Published by Wiley in Cell Biology International
- Vol. 32 (8) , 940-949
Hypoxia enhances gene expression of inducible nitric oxide synthase and matrix metalloproteinase‐9 in ras/myc‐transformed serum‐free mouse embryo cells under simulated inflammatory and infectious conditions
Ras/myc‐transformed serum‐free mouse embryo (ras/myc SFME) cells were treated with interferon‐gamma (IFN‐γ; 100 U/ml) and/or lipopolysaccharide (LPS; 0.5 μg/ml) for 24 h to simulate inflammatory and infectious conditions and investigate their effects on the expression of inducible nitric oxide synthase (iNOS) mRNA, nitric oxide (NO) and matrix metalloproteinase‐9 (MMP‐9). In addition, aminoguanidine (AG; 1 mM), a NOS inhibitor, S‐nitroso‐N‐acetyl‐dl‐penicillamine (SNAP; 10–200 μM), an NO donor or (±)‐N‐[(E)‐4‐ethyl‐2‐[(Z)‐hydroxyimino]‐5‐nitro‐3‐hexene‐1‐yl]‐3‐pyridine carboxamide (NOR4; 10–200 μM), an NO donor, were added to analyze possible associations of NO with MMP‐9. Tissue inhibitors of metalloproteinase (TIMP)‐1 and TIMP‐2 were also measured to analyze possible relationships of NO with the MMP‐9/TIMP balance. Furthermore, the cells were treated with 1% O2 under the simulated inflammatory and infectious conditions and the mRNA expressions of iNOS and MMP‐9 were analyzed to investigate the possible effects of hypoxia on the expression of genes involved in tumor malignant progression and distant metastasis. Co‐treatment with IFN‐γ and LPS increased the expression levels of iNOS mRNA, NO and MMP‐9, but NO may not be directly associated with MMP‐9 or the MMP‐9/TIMP balance. Treatment with 1% O2 markedly increased the gene expression levels of iNOS and MMP‐9, indicating that ras/myc SFME cells alter the expression levels of tumor‐associated genes and possibly enhance their malignancy as cancer cells under inflammatory, infectious and hypoxic conditions.
- 5 March 2008
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 312 (1-2) , 103-112
l-NAME inhibits tumor cell progression and pulmonary metastasis of r/m HM-SFME-1 cells by decreasing NO from tumor cells and TNF-α from macrophages
- 5 March 2008
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 312 (1-2) , 103-112
l-NAME inhibits tumor cell progression and pulmonary metastasis of r/m HM-SFME-1 cells by decreasing NO from tumor cells and TNF-α from macrophages
- Open Access
- 1 January 2008
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 31 (5) , 1008-1012
Differentiation of Serum-Free Mouse Embryo Cells into an Astrocytic Lineage is Associated with the Asymmetric Production of Early Neural, Neuronal and Glial Markers
Serum-free mouse embryo (SFME) cells, the astrocyte progenitor cells in the central nervous system (CNS), were exposed to 10 ng/ml leukemia inhibitory factor (LIF) and 10 ng/ml bone morphogenic protein 2 (BMP2) to induce differentiation, and expression of cell-type specific markers. Nestin, a marker of early neural lineage, βIII-tubulin, a marker of neuronal lineage, oligodendrocyte marker O4 (O4), a marker of oligodendrocytic lineage and glial fibrillary acidic protein (GFAP), a marker of astrocytic lineage, were analyzed. Characteristics of SFME cells, as a CNS progenitor, were identified and a possible mechanism, underlying SFME cell specification into an astrocytic lineage upon differentiation, was investigated. These markers were present, both at the initial proliferative phase and after induction of differentiation. GFAP expression increased strongly upon differentiation, while expression of the other markers changed very little. These results indicate that astrocytic differentiation is associated with the asymmetric production of these markers, rather than through induction of astrocytic markers.
- 1 January 2008
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 31 (5) , 1008-1012
Open AccessDifferentiation of Serum-Free Mouse Embryo Cells into an Astrocytic Lineage is Associated with the Asymmetric Production of Early Neural, Neuronal and Glial Markers
Serum-free mouse embryo (SFME) cells, the astrocyte progenitor cells in the central nervous system (CNS), were exposed to 10 ng/ml leukemia inhibitory factor (LIF) and 10 ng/ml bone morphogenic protein 2 (BMP2) to induce differentiation, and expression of cell-type specific markers. Nestin, a marker of early neural lineage, βIII-tubulin, a marker of neuronal lineage, oligodendrocyte marker O4 (O4), a marker of oligodendrocytic lineage and glial fibrillary acidic protein (GFAP), a marker of astrocytic lineage, were analyzed. Characteristics of SFME cells, as a CNS progenitor, were identified and a possible mechanism, underlying SFME cell specification into an astrocytic lineage upon differentiation, was investigated. These markers were present, both at the initial proliferative phase and after induction of differentiation. GFAP expression increased strongly upon differentiation, while expression of the other markers changed very little. These results indicate that astrocytic differentiation is associated with the asymmetric production of these markers, rather than through induction of astrocytic markers.
- 28 July 2007
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 306 (1-2) , 43-51
Ras/myc-transformed serum-free mouse embryo cells under simulated inflammatory and infectious conditions increase levels of nitric oxide and matrix metalloproteinase-9 without a direct association between them
Inflammatory and infectious conditions were simulated in cultures of ras/myc-transformed serum-free mouse embryo (ras/myc SFME) cells, using interferon-gamma (IFN-γ, 100 units/ml) and lipopolysaccharide (LPS, 0.5 μg/ml) co-treatment for 24 h, to investigate their effects on the expression of inducible nitric oxide synthase (iNOS) mRNA and the production of NO. Aminoguanidine (AG, 1 mM; an NOS inhibitor) along with IFN-γ and LPS, S-nitroso-N-acetyl-DL-penicillamine (SNAP, 100 μM; an NO donor) and/or (±)-N-[(E)-4-Ethyl-2-[(Z)-hydroxyimino]-5-nitro-3-hexene-1-yl]-3-pyridine carboxamide (NOR4, 100 μM; an NO donor), were also added to analyze the possible association of NO with matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1). Co-treatment of cells with IFN-γ and LPS increased iNOS mRNA expression, NO production, MMP-9 mRNA expression, and 105 kDa MMP-9 production. Additional treatment with the NOS inhibitor AG inhibited NO production, but did not down-regulate the expression of MMP-9 mRNA or 105 kDa MMP-9. The NO donors SNAP and NOR4 did not affect the expression of MMP-9 mRNA, 105 kDa MMP-9 or TIMP-1 mRNA. These results suggest that ras/myc SFME cells respond to infectious and inflammatory conditions and can enhance malignancy as cancer cells due to their increased levels of NO and MMP-9 production, but that NO is not directly associated with MMP-9 in these cells.
- 28 July 2007
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 306 (1-2) , 43-51
Ras/myc-transformed serum-free mouse embryo cells under simulated inflammatory and infectious conditions increase levels of nitric oxide and matrix metalloproteinase-9 without a direct association between them
Inflammatory and infectious conditions were simulated in cultures of ras/myc-transformed serum-free mouse embryo (ras/myc SFME) cells, using interferon-gamma (IFN-γ, 100 units/ml) and lipopolysaccharide (LPS, 0.5 μg/ml) co-treatment for 24 h, to investigate their effects on the expression of inducible nitric oxide synthase (iNOS) mRNA and the production of NO. Aminoguanidine (AG, 1 mM; an NOS inhibitor) along with IFN-γ and LPS, S-nitroso-N-acetyl-DL-penicillamine (SNAP, 100 μM; an NO donor) and/or (±)-N-[(E)-4-Ethyl-2-[(Z)-hydroxyimino]-5-nitro-3-hexene-1-yl]-3-pyridine carboxamide (NOR4, 100 μM; an NO donor), were also added to analyze the possible association of NO with matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1). Co-treatment of cells with IFN-γ and LPS increased iNOS mRNA expression, NO production, MMP-9 mRNA expression, and 105 kDa MMP-9 production. Additional treatment with the NOS inhibitor AG inhibited NO production, but did not down-regulate the expression of MMP-9 mRNA or 105 kDa MMP-9. The NO donors SNAP and NOR4 did not affect the expression of MMP-9 mRNA, 105 kDa MMP-9 or TIMP-1 mRNA. These results suggest that ras/myc SFME cells respond to infectious and inflammatory conditions and can enhance malignancy as cancer cells due to their increased levels of NO and MMP-9 production, but that NO is not directly associated with MMP-9 in these cells.
- 1 June 2007
- Published by Wiley in Cell Biology International
- Vol. 31 (6) , 638-644
Serum‐free mouse embryo cells generate a self‐sustaining feedback loop for an astrocyte marker protein and respond to cytokines and bisphenol A in accordance with the subtle difference in their differentiation state
Serum‐free mouse embryo (SFME) cells, the astrocyte progenitor cells in the central nervous system, generated a self‐sustaining feedback loop for glial fibrillary acidic protein (GFAP) expression after a period of cell passages. The period required was about 150 days (30 passages). SFME and high‐GFAP‐expressing SFME (G‐SFME) cells were exposed to 10 ng/ml leukemia inhibitory factor (LIF) and 10 ng/ml bone morphogenetic protein 2 (BMP2) to induce differentiation and their responses to cytokine signals were analyzed. Although differentiation was significantly induced in both cell types, SFME cells showed more obvious responses to the cytokine signals. Various concentrations of bisphenol A (BPA) (0.1 pg/ml to 1 μg/ml) were added to determine its effects on cell differentiation. A completely serum‐free culture was developed for effective differentiation of G‐SFME cells with LIF and BMP2, and GFAP expression was significantly increased in the presence of 1–100 pg/ml BPA. These increases were attributed to excessive activation of signal transducer and activator of transcription 3 (STAT3) and mothers against decapentaplegic homolog 1 (Smad1) by the low‐level BPA. The data obtained in the present study revealed that the sensitivity of the cells to LIF, BMP2 and BPA could change upon cell differentiation, suggesting that the cells may possibly respond differently to cytokines and endocrine disruptors depending on subtle differences in their differentiation state.
- 1 June 2007
- Published by Wiley in Cell Biology International
- Vol. 31 (6) , 638-644
Serum‐free mouse embryo cells generate a self‐sustaining feedback loop for an astrocyte marker protein and respond to cytokines and bisphenol A in accordance with the subtle difference in their differentiation state
Serum‐free mouse embryo (SFME) cells, the astrocyte progenitor cells in the central nervous system, generated a self‐sustaining feedback loop for glial fibrillary acidic protein (GFAP) expression after a period of cell passages. The period required was about 150 days (30 passages). SFME and high‐GFAP‐expressing SFME (G‐SFME) cells were exposed to 10 ng/ml leukemia inhibitory factor (LIF) and 10 ng/ml bone morphogenetic protein 2 (BMP2) to induce differentiation and their responses to cytokine signals were analyzed. Although differentiation was significantly induced in both cell types, SFME cells showed more obvious responses to the cytokine signals. Various concentrations of bisphenol A (BPA) (0.1 pg/ml to 1 μg/ml) were added to determine its effects on cell differentiation. A completely serum‐free culture was developed for effective differentiation of G‐SFME cells with LIF and BMP2, and GFAP expression was significantly increased in the presence of 1–100 pg/ml BPA. These increases were attributed to excessive activation of signal transducer and activator of transcription 3 (STAT3) and mothers against decapentaplegic homolog 1 (Smad1) by the low‐level BPA. The data obtained in the present study revealed that the sensitivity of the cells to LIF, BMP2 and BPA could change upon cell differentiation, suggesting that the cells may possibly respond differently to cytokines and endocrine disruptors depending on subtle differences in their differentiation state.
- 1 September 2006
- Published by Elsevier in Toxicology
- Vol. 226 (2-3) , 131-142
Low-level bisphenol A increases production of glial fibrillary acidic protein in differentiating astrocyte progenitor cells through excessive STAT3 and Smad1 activation
- 1 September 2006
- Published by Elsevier in Toxicology
- Vol. 226 (2-3) , 131-142
Low-level bisphenol A increases production of glial fibrillary acidic protein in differentiating astrocyte progenitor cells through excessive STAT3 and Smad1 activation
- 30 April 2003
- Published by Elsevier in Food Control
- Vol. 14 (3) , 201-206
Two detection methods of genetically modified maize and the state of its import into Japan
- 30 April 2003
- Published by Elsevier in Food Control
- Vol. 14 (3) , 201-206
Two detection methods of genetically modified maize and the state of its import into Japan
- 1 May 2002
- Published by Taylor & Francis in Archives of Environmental Health: An International Journal
- Vol. 57 (3) , 232-238
Toluene at Environmentally Relevant Low Levels Disrupts Differentiation of Astrocyte Precursor Cells
Recent findings that describe endocrine disruption caused by exposure to low levels of certain chemicals in the environment have led to a paradigm shift in the way toxicology studies are designed. Toluene at high levels damages the human central nervous system; however, the effects of toluene at low levels have not been studied. The authors used serum-free mouse embryo cells—a precursor of astrocytes—to predict the effect of chemicals on developing brain cells. When serum-free mouse embryo cells were exposed to low levels of toluene, induction of glial fibrillary acidic protein was inhibited. This study demonstrated that environmentally relevant low levels of toluene could disrupt normal prenatal brain development.
- 1 May 2002
- Published by Taylor & Francis in Archives of Environmental Health: An International Journal
- Vol. 57 (3) , 232-238
Toluene at Environmentally Relevant Low Levels Disrupts Differentiation of Astrocyte Precursor Cells
Recent findings that describe endocrine disruption caused by exposure to low levels of certain chemicals in the environment have led to a paradigm shift in the way toxicology studies are designed. Toluene at high levels damages the human central nervous system; however, the effects of toluene at low levels have not been studied. The authors used serum-free mouse embryo cells—a precursor of astrocytes—to predict the effect of chemicals on developing brain cells. When serum-free mouse embryo cells were exposed to low levels of toluene, induction of glial fibrillary acidic protein was inhibited. This study demonstrated that environmentally relevant low levels of toluene could disrupt normal prenatal brain development.